roflumilast
arcutis,astrazeneca
['derm', 'roflumilast', 'arcutis', '$arqt']
$arqt [15s. delayed]: issued press release on september 09, 08:15:00: new data from arcutis stratum pivotal phase 3 trial of roflumilast foam 0.3% in seborrheic dermatitis presented at european academy of dermatology and venereology (eadv) congress 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time